163 related articles for article (PubMed ID: 9249189)
1. Indicators of salivary gland inflammation in primary Sjogren's syndrome.
Cuida M; Halse AK; Johannessen AC; Tynning T; Jonsson R
Eur J Oral Sci; 1997 Jun; 105(3):228-33. PubMed ID: 9249189
[TBL] [Abstract][Full Text] [Related]
2. s-IgA and cytokine levels in whole saliva of Sjögren's syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study.
Rhodus N; Dahmer L; Lindemann K; Rudney J; Mathur A; Bereuter J
Clin Oral Investig; 1998 Dec; 2(4):191-6. PubMed ID: 10388393
[TBL] [Abstract][Full Text] [Related]
3. Sjögren's syndrome in inflammatory rheumatic diseases: analysis of the leukocyte protein calprotectin in plasma and saliva.
Brun JG; Cuida M; Jacobsen H; Kloster R; Johannesen AC; Høyeraal HM; Jonsson R
Scand J Rheumatol; 1994; 23(3):114-8. PubMed ID: 8016580
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome.
Markusse HM; Otten HG; Vroom TM; Smeets TJ; Fokkens N; Breedveld FC
Clin Immunol Immunopathol; 1993 Jan; 66(1):26-32. PubMed ID: 8440071
[TBL] [Abstract][Full Text] [Related]
5. Salivary calprotectin levels are raised in patients with oral candidiasis or Sjögren's syndrome but decreased by HIV infection.
Sweet SP; Denbury AN; Challacombe SJ
Oral Microbiol Immunol; 2001 Apr; 16(2):119-23. PubMed ID: 11240866
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum soluble interleukin-2 receptor in primary Sjögren's syndrome.
Tishler M; Yaron I; Shirazi I; Levartovsky D; Yaron M
Arch Oral Biol; 1999 Apr; 44(4):305-8. PubMed ID: 10348356
[TBL] [Abstract][Full Text] [Related]
7. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjögren's syndrome.
Iwasaki K; Okawa-Takatsuji M; Aotsuka S; Ono T
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Dec; 26(6):346-54. PubMed ID: 14752936
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the concentration and output of whole salivary constituents in patients with Sjögren's syndrome.
van der Reijden WA; van der Kwaak JS; Veerman EC; Nieuw Amerongen AV
Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):335-40. PubMed ID: 8930579
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.
Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U
J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769
[TBL] [Abstract][Full Text] [Related]
10. Increased beta 2-microglobulin in both parotid and submandibular/sublingual saliva from patients with Sjögren's syndrome.
Mogi M; Kage T; Chino T; Yoshitake K; Harada M
Arch Oral Biol; 1994 Oct; 39(10):913-5. PubMed ID: 7741662
[TBL] [Abstract][Full Text] [Related]
11. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
[TBL] [Abstract][Full Text] [Related]
12. Platelet involvement in salivary gland inflammation in patients with primary Sjögren's syndrome.
Oxholm P; Winther K
Rheumatol Int; 1987; 7(1):29-33. PubMed ID: 2954201
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional electrophoresis of human salivary proteins from patients with sialoadenopathy.
Mogi M; Harada M; Kage T; Chino T; Yoshitake K
Arch Oral Biol; 1993 Dec; 38(12):1135-9. PubMed ID: 8141677
[TBL] [Abstract][Full Text] [Related]
14. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) and neopterin in patients with Sjögren's syndrome.
Andrýs C; Krejsek J; Slezák R; Drahosová M; Kopecký O
Acta Medica (Hradec Kralove); 1999; 42(3):97-101. PubMed ID: 10677896
[TBL] [Abstract][Full Text] [Related]
16. TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.
Vosters JL; Roescher N; Illei GG; Chiorini JA; Tak PP
Oral Dis; 2012 May; 18(4):365-74. PubMed ID: 22212434
[TBL] [Abstract][Full Text] [Related]
17. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
[TBL] [Abstract][Full Text] [Related]
18. Xerostomia in Sjögren's syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations.
Fernandes JD; Nico MM; Aoki V; Bologna S; Romiti R; Levy-Neto M; Lourenço SV
J Cutan Pathol; 2010 Apr; 37(4):432-8. PubMed ID: 19614726
[TBL] [Abstract][Full Text] [Related]
19. Clinical utilization of sialochemistry in Sjögren's syndrome.
Stuchell RN; Mandel ID; Baurmash H
J Oral Pathol; 1984 Jun; 13(3):303-9. PubMed ID: 6204031
[TBL] [Abstract][Full Text] [Related]
20. Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations.
Delaleu N; Immervoll H; Cornelius J; Jonsson R
Arthritis Res Ther; 2008; 10(1):R22. PubMed ID: 18289371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
